probiotics

Flow cytometry: from Biofarma Group, a new approach for probiotic counting

A team of researchers have carried out a study on the search for bacterial probiotics, using a new method: flow cytometry

Consumer behavior in probiotic consumption

MicrobiomePost carried out a research analysis in collaboration with Analytics Arts to find out more about the motivations and frequency of probiotic consumption and the level of consumer information.

Revolutionizing skin health: advanced probiotic-oil suspension to transform microbial balance in seborrheic dermatitis

Researchers at the San Gallicano Dermatological Institute in Rome, Italy, conducted an open-label exploratory trial to assess the therapeutic potential of EUTOPLAC, a topical probiotic containing Lactobacillus crispatus P 17631…

Probiotics for women’s health: new evidence in post-menopausal women

Harnessing the benefits of L. plantarum PBS067, L. rhamnosus LRH020, and B. lactis BL050 for post-menopausal symptom relief.

AI and the Microbiome: Crafting the Future of Health with Evogene and Verb Biotics

Two pioneering companies are poised to explore the genetic frontiers of probiotic bacteria, seeking out strains that can produce sustainable quantities of life-enhancing microbial metabolites.

Don’t miss the 10th International Human Microbiome Consortium (IHMC) Congress 2024

Alessio Fasano gives an overview of the IHMC Congress to be held in Rome, 22-25 June.

Explore the latest update from SynBalance on the gut-skin axis

Join SynBalance, platinum sponsor at Probiota Global 2024 (7-9 February, Milan), and discover the newst scientific data on ProBeautyShield, the probiotic ingredient designed for skin health.

Mixture of milk sugars and live bacteria may restore damaged gut microbiotas

The findings of a recent study suggest that a mixture of B. infantis and HMOs can modulate the gut microbiota in adults.

Boehringer Ingelheim acquires T3 Pharma, boosting immuno-oncology efforts

In a significant move to expand its immuno-oncology portfolio, Boehringer Ingelheim has acquired T3 Pharmaceuticals AG, a Swiss biotech company specializing in bacterial cancer therapy.

In silico trials: the avant-garde of clinical trials in support of Biofarma Group’s product Epatrex

Epatrex, a new nutraceutical compound formulated as a three-layer tablet containing the probiotic Lactobacillus casei LC-XCAL.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top